Article
Loss of Bard1, the heterodimeric partner of the Brca1 tumor suppressor, results in early embryonic lethality and chromosomal instability.
Molecular and cellular biology - 1 Jul 2003
McCarthy Ellen E, Celebi Julide T, Baer Richard, Ludwig Thomas
Abstract excerpt
The BRCA1 tumor suppressor has been implicated in many cellular pathways, but the mechanisms by which it suppresses tumor formation are not fully understood. In vivo BRCA1 forms a heterodimeric complex with the related BARD1 protein, and its enzymatic activity as a ubiquitin ligase is largely dep...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
